MedPath

Effects of Anaesthesia on Inflammatory Markers

Not Applicable
Completed
Conditions
Inflammatory Response
Interventions
Drug: morphine+lidocaine
Drug: Saline
Registration Number
NCT04630938
Lead Sponsor
Assiut University
Brief Summary

undertake confidently both open and laparoscopic cholecystectomy. Major types of body injuries surgical or accidental; evoke a temporary, yet predictable systemic inflammatory response caused by hormonal, immunological and metabolic mediators. This inflammatory response is essential for tissue repair and has evolved to maximize the organisms' healing potential. In healthy individuals the inflammatory response to major surgery is well balanced consisting of pro- and anti-inflammatory mediators. The severity of injury, the occurrence of surgical complications and its accompanying level of stress may hinder the balance of the inflammatory response6.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
81
Inclusion Criteria
  • Adult patients aging 18 - 55 years old
  • Patients scheduled for abdominal surgeries
  • Patients with American Society of Anesthesiologists (ASA) I, II physical status
Exclusion Criteria
  • Patients' refusal.
  • Critically ill patients.
  • Patients who have contraindications to regional anesthesia.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
G-MLmorphine+lidocaineReceived classic general Anesthesia, intrathecal morphine in a dose of 4 microgram/kg, and intravenous lidocaine in a loading dose of 1.5 mg/kg, then 2 mg/min with the saline infusion over the time of the operation and the next 4 hours postoperative.
G-0SalineReceived General Anesthesia and Spinal anesthesia as previously described with saline infusion in the same design as in the previous two groups.
G-MMorphine SulfateReceived classic general Anesthesia, intrathecal (Bupivacaine 15 mg, morphine 4 microgram/kg) plus saline infusion intraoperative and postoperative.
Primary Outcome Measures
NameTimeMethod
Visual analogue score24 hours

a scale to measure pain intensity graded from 0 = no pain to 10 = worst pain

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Esam A. Hamed

🇪🇬

Assiut, Egypt

Esam A. Hamed
🇪🇬Assiut, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.